Literature DB >> 17064640

Urinary tract infection in women: new pathogenic considerations.

Ann E Stapleton1.   

Abstract

Urinary tract infection (UTI) is a common clinical syndrome in women. Most UTIs are caused by Escherichia coli. UTI has become a productive and accessible model system for studying the molecular details of how bacteria interact with mucosal surfaces and the nature of the host response. Important advances in the past year include the discovery of new virulence determinants; better understanding the pathogenic role of the ubiquitous motility organelle, the flagellum; and defining aspects of coordinate regulation of virulence determinants in the pathogenesis of UTI.

Entities:  

Year:  2006        PMID: 17064640     DOI: 10.1007/s11908-006-0021-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  67 in total

1.  Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: a pilot study.

Authors:  James A Greenberg; Sara J Newmann; Amy B Howell
Journal:  J Altern Complement Med       Date:  2005-10       Impact factor: 2.579

2.  Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing.

Authors:  Sara Y Tartof; Owen D Solberg; Amee R Manges; Lee W Riley
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Urinary tract infection: self-reported incidence and associated costs.

Authors:  B Foxman; R Barlow; H D'Arcy; B Gillespie; J D Sobel
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

4.  Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice; Chia S Hung; Scott R Lauer; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins.

Authors:  Philippe Bidet; Stéphane Bonacorsi; Olivier Clermont; Caroline De Montille; Naima Brahimi; Edouard Bingen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor.

Authors:  Simon Léveillé; Mélissa Caza; James R Johnson; Connie Clabots; Mourad Sabri; Charles M Dozois
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Mucosal host responses to bacteriuria in colonic and ileal neobladders.

Authors:  Björn Wullt; Göran Bergsten; Jens Carstensen; Elisabeth Gustafsson; Negash Gebratsedik; Elisabet Holst; Wiking Månsson
Journal:  Eur Urol       Date:  2006-02-24       Impact factor: 20.096

8.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Sheryl S Justice; Chia Hung; Julie A Theriot; Daniel A Fletcher; Gregory G Anderson; Matthew J Footer; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

9.  Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.

Authors:  Katherine L Meyer-Siegler; Kenneth A Iczkowski; Pedro L Vera
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

10.  Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.

Authors:  M Hedlund; M Svensson; A Nilsson; R D Duan; C Svanborg
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.